文献速递产科母胎医学

严重胎儿生长受限中胎盘胎儿血管灌注异常的2岁神经发育结局

Placental features of fetal vascular malperfusion and infant neurodevelopmental outcomes at 2 years of age in severe fetal growth restriction.
PubMed 文献 · Am J Obstet Gynecol · 2021-04-01

该观察性队列纳入2007至2016年单中心≤34周、出生体重≤1500g的单胎胎儿生长受限妊娠249例,分析胎盘母体及胎儿血管灌注异常与婴儿2岁神经发育结局的关系。严重母体血管灌注异常与新生儿死亡风险升高相关(aOR 3.3),胎儿血管灌注异常与2岁神经发育异常风险显著升高相关(严重者aOR 24.5)。

要点

  • 严重母体血管灌注异常与新生儿死亡风险升高相关(aOR 3.3,95%CI 1.2-9.5)。
  • 严重胎儿血管灌注异常者2岁神经发育后遗症发生率为57.1%(4/7),aOR 24.5。
  • 胎儿血管灌注异常者2岁正常神经发育存活可能性降低超70%(aOR 0.29)。

核心结论

  • 早产胎儿生长受限中,胎盘胎儿血管灌注异常与2岁婴儿神经发育异常风险升高相关,即使新生儿出院时无脑损伤或神经系统异常。

研究设计与样本

  • 观察性队列研究,纳入2007至2016年单中心≤34周、出生体重≤1500g的单胎胎儿生长受限妊娠249例。

主要发现

  • 249例中新生儿死亡率为8.8%(22/249),严重和总体母体血管灌注异常分别为16.1%(40/249)和31.7%(79/249)。
  • 严重母体血管灌注异常与新生儿死亡风险升高相关(aOR 3.3;95%CI 1.2-9.5)。
  • 198例存活并完成2年随访者中,严重胎儿血管灌注异常、总体胎儿血管灌注异常和无胎儿血管灌注异常者的主要和次要神经发育后遗症发生率分别为57.1%(4/7)、44.8%(13/29)和7.1%(12/169)。
  • 严重胎儿血管灌注异常aOR 24.5(95%CI 4.1-146),总体胎儿血管灌注异常aOR 5.8(95%CI 5.1-16.2)。
  • 胎儿血管灌注异常者2岁总体商、个人-社会、听力和言语及表现子量表评分较低,正常神经发育存活可能性降低超70%(aOR 0.29;95%CI 0.14-0.63)。

临床怎么用

  • 早产胎儿生长受限伴胎盘胎儿血管灌注异常时,应警惕2岁神经发育异常风险,即使新生儿出院时无神经系统异常。
  • 诊断为胎儿血管灌注异常时,应提醒儿科和神经科医生关注后续婴儿神经发育问题。

局限性

  • 单中心观察性队列研究,结果外推需谨慎。
  • 严重胎儿血管灌注异常组样本量小(7例),估计值置信区间宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Placental pathologic lesions suggesting maternal or fetal vascular malperfusion are common among pregnancies complicated by intrauterine growth restriction. Data on the relationship between pathologic placental lesions and subsequent infant neurodevelopmental outcomes are limited. OBJECTIVE: This study aimed to assess the relationship between placental pathologic lesions and infant neurodevelopmental outcomes at 2 years of age in a cohort of pregnancies complicated by intrauterine growth restriction. STUDY DESIGN: An observational cohort study included singleton intrauterine growth restriction pregnancies delivered at ≤34 weeks' gestation and with a birthweight of ≤1500 g at a single institution in the period between 2007 and 2016. Maternal and neonatal data were collected at discharge from the hospital. Infant neurodevelopmental assessment was performed every 3 months during the first year of life and every 6 months in the second year. Penalized logistic regression was used to test the association of maternal vascular malperfusion and fetal vascular malperfusion with infant outcomes adjusting for confounders. RESULTS: Of the 249 pregnancies enrolled, neonatal mortality was 8.8% (22 of 249). Severe and overall maternal vascular malperfusion were 16.1% (40 of 249) and 31.7% (79 of 249), respectively. Severe maternal vascular malperfusion was associated with an increased risk of neonatal mortality (adjusted odds ratio, 3.3; 95% confidence interval, 1.2-9.5). Among the 198 survivors after a 2-year neurodevelopmental follow-up evaluation, the rate of major and minor neurodevelopmental sequelae was 57.1% (4 of 7) among severe fetal vascular malperfusion (adjusted odds ratio, 24.5; 95% confidence interval, 4.1-146), 44.8% (13 of 29) among overall fetal vascular malperfusion (adjusted odds ratio, 5.8; 95% confidence interval, 5.1-16.2), and 7.1% (12 of 169) in pregnancies without fetal vascular malperfusion. Infants born from pregnancies with fetal vascular malperfusion also had lower 2-year general quotient, personal-social, hearing and speech, and performance subscales scores than those without fetal vascular malperfusion. Finally, in the presence of fetal vascular malperfusion, the likelihood of a 2-year infant survival with normal neurodevelopmental outcomes was reduced by more than 70% (adjusted odds ratio, 0.29; 95% confidence interval, 0.14-0.63). Noticeably, 10 of the 20 subjects with a 2-year major neurodevelopmental impairment (3 of 4 with severe fetal vascular malperfusion) had little or no abnormal neurologic findings at discharge from neonatal intensive care unit. CONCLUSION: In preterm intrauterine growth restriction, placental fetal vascular malperfusion is correlated with an increased risk of abnormal infant neurodevelopmental outcomes at 2 years of age even in the absence of brain lesions or neurologic abnormalities at discharge from the neonatal intensive care unit. In the case of a diagnosis of fetal vascular malperfusion, pediatricians and neurologists should be alerted to an increased risk of subsequent infant neurodevelopmental problems.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gardella B, Dominoni M, Caporali C, et al. Placental features of fetal vascular malperfusion and infant neurodevelopmental outcomes at 2 years of age in severe fetal growth restriction. Am J Obstet Gynecol. 2021. PMID: 33812813. doi:10.1016/j.ajog.2021.03.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。